M. L. Levy (Kenton, UK), O. C. P. Van Schayck (Maastricht, The Netherlands)
The role of the practice nurse in the management of asthma
R. C. M. Jones, S. P. Freegard, M. A. Reeves, K. E. Hanney (Plymouth, United Kingdom)
|  |
The role of the practice nurse in the management of COPD
R. C. M. Jones, S. P. Freegard, M. A. Reeves, K. E. Hanney (Plymouth, United Kingdom)
| |
Is spirometry in general practice adequately performed or not? Preliminary data of an evaluation study in patients with COPD
T. R. J. Schermer, N. Chavannes, A. Jacobs, H. Folgering, B. Bottema (Nijmegen, Maastricht, The Netherlands)
| |
Evaluating the use of spirometry in primary care
A. D. Lawrence, S. A. Haggerty, N. P. Keaney (Sunderland, United Kingdom)
| |
Identifying patients with chronic obstructive pulmonary disease on an asthma register in primary care
D. M. Scott, S. A. Haggerty, A. D. Lawrence (Sunderland, United Kingdom)
| |
Identifying important factors in 'poorly controlled' asthma patients
G. Hoskins, C. McCowan, G. E. Thomas, B. Smith, F. Everhard (Dundee, United Kingdom; Basel, Switzerland)
| |
Medication use in children with asthma: a case control study
I. K. Crombie, L. Irvine, E. M. Alder, R. G. Neville, R. A. Clark (Dundee, Edinburgh, Brechin, United Kingdom)
| |
Cost of asthma exacerbations managed in primary care in Spain
J. Molina, E. Calvo, E. Cimas, E. Hernandez, M. A. Lobo, M. A. Llauger, P. Martin, K. Naberan, L. Olmo, J. I. Sanchez, A. Kielhorn, J. F. Alonso (Madrid, Spain; Greenford, United Kingdom)
| |
The role of coping resources and coping style on quality of life in patients with asthma or COPD
A. E. Hesselink, B. W. J. H. Penninx, H. A. H. Wijnhoven, D. A. W. M. van der Windt, J. T. M. van Eijk (Amsterdam, Maastricht, The Netherlands; Winston-Salem, United States Of America)
| |
Breathing retraining improves quality of life in asthmatic patients with dysfunctional breathing
M. Thomas, R. K. McKinley, P. Prodger, E. Freeman, C. Foy (Gloucestershire, Leicester, Gloucester, United Kingdom)
| |
Asthma control and juniper's asthma control questionnary (ACQ) in 1333 French patients: the JACINTE survey
Y. Rogeaux, Y. Martinat, K. Mezzi (Villeneuve d'Ascq, Lyon, Cergy, France)
| |
Addition of formoterol Turbuhaler® to budesonide Turbuhaler® is safe and well tolerated in the long-term treatment of mild asthma: results from the OPTIMA trial
P. M O'Byrne, P. J Barnes, R. Rodriguez-Roisin, T. Sandström, A. E. Tattersfield, E. M Runnerström, K. Svensson (Hamilton, ON, Canada; London, Nottingham, United Kingdom; Barcelona, Spain; Umea, Lund, Sweden)
| |
Formoterol Turbuhaler® twice daily is more cost-effective than salmeterol twice daily or as-needed salbutamol
F. E. Berggren, K. Svensson, M. S. Rolnick, S. Mintz, On behalf of the Canadian Investigators (Lund, Sweden; Mississauga, Toronto, Canada)
| |
Economic results of adding formoterol to budesonide in mild persistent asthma
B. G. Jönsson, F. E. Berggren, K. Svensson, P. M. O'Byrne (Stockholm, Lund, Sweden; Hamilton, Canada)
| |
Long-term benefits of switching to hydrofluoroalkane beclomethasone dipropionate extrafine aerosol
M. Laviolette, B. M. Prenner, W. Vincken, S. J. M. Mol (Quebec, Canada; San Diego, United States Of America; Brussels, Belgium; Veldhoven, The Netherlands)
| |
Maintenance of bronchodilation following tiotropium in patients with mild, moderate and severe COPD in one year clinical trials
W. G. Vincken, P. Vermiere, S. S. Menjoge, S. Kesten, P. J. G. Cornelissen (Brussels, Antwerp, Belgium; Ridgefield, United States Of America; Alkmaar, The Netherlands)
| |